Seretide Competition Builds Up But Substitutability Holds Key?
This article was originally published in Scrip
Executive Summary
More possible competition is building for GlaxoSmithKline's blockbuster salmeterol and fluticasone combination, with a second Indian firm teaming up with the Polish biopharmaceutical company Celon to produce a version of the product.